Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nevro Corp (NY: NVRO )

176.32 USD +0.36 (+0.20%)
Official Closing Price Updated: 4:43 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 392,406
Open 175.37
Bid (Size) 165.94 (1)
Ask (Size) 180.00 (1)
Prev. Close 175.96
Today's Range 173.90 - 180.38
52wk Range 65.05 - 188.14
Shares Outstanding 29,978,926
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Clinical Data Presented at 2021 North American Neuromodulation Society (NANS) Virtual Meeting Reinforce Significant Benefits of Nevro's HF10® Therapy
PDN Randomized Trial Demonstrates Significantly Improved and Sustained Outcomes 
From PR Newswire
Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations... 
From PR Newswire

Performance

YTD
+2.79%
+2.79%
1 Month
-1.15%
-1.15%
3 Month
+12.49%
+12.49%
6 Month
+35.89%
+35.89%
1 Year
+32.07%
+32.07%

More News

Read More
Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2020 Revenue
From PR Newswire
Nevro Announces FDA Submission for HF10® Therapy in Patients with Painful Diabetic Neuropathy
From PR Newswire
Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California
From PR Newswire
Nevro to Host Virtual Investor Briefing at 2021 North American Neuromodulation Society (NANS) Virtual Conference
From PR Newswire
Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021
From PR Newswire
Nevro Announces Agreement to Conclude Its Patent Lawsuit in the Northern District of California Against Boston Scientific
From PR Newswire
Nēsos Unveils First-of-its-Kind Wireless Earbud for the Treatment of Rheumatoid Arthritis
From WebWire
Nevro Announces Director Appointment
From PR Newswire
Notable Thursday Option Activity: NVRO, BCOR, UBER
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]